Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Change in Accured Expenses (2016 - 2025)

Orthopediatrics (KIDS) has disclosed Change in Accured Expenses for 10 consecutive years, with $458000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses rose 100.0% to $458000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.2 million, a 132.4% increase, with the full-year FY2025 number at $1.2 million, up 132.4% from a year prior.
  • Change in Accured Expenses was $458000.0 for Q4 2025 at Orthopediatrics, up from -$1.7 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $6.0 million in Q2 2024 to a low of -$5.0 million in Q1 2024.
  • A 5-year average of $653800.0 and a median of $546000.0 in 2021 define the central range for Change in Accured Expenses.
  • Peak YoY movement for Change in Accured Expenses: soared 344.77% in 2021, then tumbled 254.71% in 2022.
  • Orthopediatrics' Change in Accured Expenses stood at $1.3 million in 2021, then grew by 22.25% to $1.5 million in 2022, then skyrocketed by 130.83% to $3.6 million in 2023, then crashed by 93.57% to $229000.0 in 2024, then surged by 100.0% to $458000.0 in 2025.
  • Per Business Quant, the three most recent readings for KIDS's Change in Accured Expenses are $458000.0 (Q4 2025), -$1.7 million (Q3 2025), and $5.0 million (Q2 2025).